104 results
8-K
EX-3.2
APGN
Apexigen Inc
23 Aug 23
Completion of Acquisition or Disposition of Assets
9:01am
and primarily responsible for the payment to the Indemnified Parties in respect of indemnification or advancement of expenses in connection with any
8-K
EX-3.1
APGN
Apexigen Inc
23 Aug 23
Completion of Acquisition or Disposition of Assets
9:01am
be fully and primarily responsible for the payment to the Indemnified Parties in respect of indemnification or advancement of expenses in connection
DEFM14A
lgeu5ig5fe5 17
30 Jun 23
Proxy related to merger
4:21pm
425
4ki2xagn g5nqahxdc
24 May 23
Business combination disclosure
7:05am
8-K
EX-2.1
wj85tai4tfylmxmh7gv6
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
8-K
EX-99.1
6kvpmk10 f8fensc
24 May 23
Pyxis Oncology to Acquire Apexigen
7:02am
424B3
yju xmnnvbrn
10 Apr 23
Prospectus supplement
4:03pm
424B3
hhwuzv9 vwtkydnghech
10 Apr 23
Prospectus supplement
4:02pm
POS AM
zk4s1k35
4 Apr 23
Prospectus update (post-effective amendment)
4:24pm
POS AM
hgrc264qum8zks5 k16
4 Apr 23
Prospectus update (post-effective amendment)
4:23pm
S-8
EX-4.2
0tbj9q 9e8
6 Oct 22
Registration of securities for employees
7:58pm